ClinicalTrials.gov
public full text
Public Domain
Efficacy of Lactobacillus Paracasei PS23 for Patients With Post-COVID-19 Syndrome
To evaluate whether probiotics PS23 can improve the symptoms of patients with long COVID-19 ; also to evaluate the effects on blood cortisol and inflammation-related indicators in patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Probiotic Use for Recovery Enhancement From Long COVID-19#867005
- Efficacy of a psychotherapeutic group intervention for patients with Post-COVID-19 condition: a randomized controlled trial (PsyLoCo study).#395887
- A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.#1086199
- Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly#424238
- Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination#860963
Record · ID 1007582
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive